research use only

Phenoxybenzamine HCl Adrenergic Receptor antagonist

Cat.No.S2499

Phenoxybenzamine HCl (NSC 37448, NCI-c01661) is a non-specific, irreversible alpha antagonist with an IC50 of 550 nM.
Jump to

Quality Control

Batch: S249901 DMSO]68 mg/mL]false]Ethanol]68 mg/mL]false]Water]17 mg/mL]false Purity: 99.06%
99.06

Solubility

In vitro
Batch:

DMSO : 68 mg/mL (199.82 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 68 mg/mL

Water : 17 mg/mL

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 340.3 Formula

C18H22ClNO.HCl

Storage (From the date of receipt)
CAS No. 63-92-3 Download SDF Storage of Stock Solutions

Synonyms NSC 37448, NCI-c01661 SMILES CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2.Cl

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Targets/IC50/Ki
α-adrenergic receptor

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2025-06-12)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05702944 RECRUITING
Pheochromocytoma; Paraganglioma; Adrenalectomy; Status; Adrenergics Causing Adverse Effects in Therapeutic Use
Seoul National University Hospital
2023-01-18 PHASE4
NCT03176693 COMPLETED
Pheochromocytoma; Paraganglioma
University of California, Los Angeles
2017-05-05 PHASE3
NCT01379898 COMPLETED
Pheochromocytoma
University Medical Center Groningen
2011-12 PHASE4
NCT01379898 Completed
Pheochromocytoma
University Medical Center Groningen|Radboud University Medical Center|UMC Utrecht|VU University of Amsterdam|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Leiden University Medical Center|Erasmus Medical Center|Maastricht University Medical Center|St. Antonius Hospital|Medisch Spectrum Twente|Maxima Medical Center|Canisius-Wilhelmina Hospital|Onze Lieve Vrouwe Gasthuis|Atrium Medical Center|Isala
2011-12 Phase 4
NCT00770705 WITHDRAWN
Congenital Heart Disease
Vanderbilt University
2008-10 PHASE2
NCT00569855 COMPLETED
Open-heart Surgery; Cardiopulmonary Bypass
University of Arkansas
2001-02 PHASE2

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map